Neighbourhood Pharmacies provided Health Canada with series of operational, economic and workflow recommendations to consider as it evaluates effectiveness and safety of the registry-based Clozapine controlled distribution program.
We believe the closed distribution model for Clozapine imposes unnecessary administrative burdens, disrupts patient care, and unfairly shifts costs and liability to community pharmacies. Neighbourhood Pharmacies is in favour of changes that lessen the administrative load while maintaining patient safety and fair access to Clozapine.
Read our submission for more information.
Neighbourhood Pharmacies Supports Removing Clozapine Closed Distribution Requirements
Submission to Health Canada Marketed Health Products Directorate